Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Ascot Announces the Retirement of Bob Evans and Appoints A New Director
-
Lyra Therapeutics (LYRA) Appoints Jason Cavalier as CFO
-
Lyra Therapeutics Appoints Jason Cavalier as Chief Financial Officer
-
Lyra Therapeutics Appoints Jason Cavalier as Chief Financial Officer
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $165 as Cantor Fitzgerald Sees 61% Upside
-
UPDATE: Cantor Fitzgerald Starts eFFECTOR Therapeutics, Inc. (EFTR) at Overweight
-
Amarin to Participate in September Investment Conferences
-
Amarin to Participate in September Investment Conferences
-
'Like an eternal flame': Americans honor the fallen on 20th anniversary of Sept. 11
-
Cantor Fitzgerald and BGC Partners' Charity Day 2021: Never Forget by Giving Back
-
AcelRx Pharmaceuticals to Participate in Two September Investor Conferences
-
Field Trip Health Ltd. to Participate in Four Investor Conferences in September
-
Future Health ESG Corp (FHLTU) Prices 20M Unit IPO at $10/unit
-
Future Health ESG Corp. Announces Pricing of $200 Million Initial Public Offering
-
Millennial Lithium Corp (ML:CN) (MLNLF) PT Raised to Cdn$3.85 at Cantor Fitzgerald
-
Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies
-
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Movius, a Leader in Secure Unified Communications, Acquires Cognitive CX and AI Provider Intentico
-
Mereo BioPharma to Participate in Three Upcoming Investor Conferences
-
Mereo BioPharma to Participate in Three Upcoming Investor Conferences
-
Ashvattha Therapeutics Announces Participation at Upcoming Investor Conferences
-
BrainsWay to Participate in Two Upcoming Investor Conferences
-
Seelos Therapeutics to Participate in Two Investor Conferences in September
-
Humanigen Inc. (HGEN) 'Investment Thesis on Stock Remains Intact' Analyst
-
TortoiseEcofin Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Redeemable Warrants, Commencing September 9, 2021
-
TortoiseEcofin Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Redeemable Warrants, Commencing September 9, 2021
-
Regeneron Announces Investor Conference Presentations
-
H.E.R., Brad Paisley, Common, and Maroon 5 to Headline SHINE A LIGHT, a Worldwide Television Special by Nonprofit 9/11 Day for the 20-year Remembrance of 9/11; with Special Message from Robert De Niro
-
Cantor Fitzgerald Upgrades Hecla Mining (HL) to Overweight
-
SCYNEXIS to Participate in Upcoming Investor Conferences
-
Sanofi to acquire Kadmon to further strengthen growth of transplant business
-
Cyclerion Therapeutics to Participate in Two Upcoming Investor Conferences
-
Cyclerion Therapeutics to Participate in Two Upcoming Investor Conferences
-
Cyclacel Pharmaceuticals Presenting at Three Conferences in September
-
Cyclacel Pharmaceuticals Presenting at Three Conferences in September
-
Kadmon (KDMN) Acquired by Sanofi (SNY) for $9.50/sh or $1.9B
-
Sanofi to acquire Kadmon to further strengthen growth of transplant business
-
Sanofi to acquire Kadmon to further strengthen growth of transplant business
-
Sanofi To Acquire Kadmon To Further Strengthen Growth of Transplant Business
-
Sarepta Therapeutics to Present at Upcoming Investor Conferences
-
Insight Acquisition Corp. Announces Closing of $240 Million Initial Public Offering
-
Marker Therapeutics to Present at Three Upcoming September Investor Conferences
-
Tivity Health to Participate in Upcoming Investor Conferences
-
DTRT Health Acquisition Corp. Announces Closing of $230 Million Initial Public Offering
-
First Cobalt Corp (FCC:CN) (FTSSF) PT Lowered to Cdn$0.50 at Cantor Fitzgerald
-
PAVmed to Participate in September Investor and MedTech Conferences
-
Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences
-
Agile Therapeutics to Participate in Upcoming Investor Conferences
-
Crinetics Pharmaceuticals to Participate in September Investor Conferences

